AVSF - StradBio 2026, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Oct 16, 2026, it has sold $386,750 of interests to 34 investors since its first sale in Oct 2026. The minimum investment it accepts from an outside investor is $5,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Michael Collins.
- Total raised
- $386,750Cumulative sales reported on Form D
- Investors
- 34
- First sale
- Oct 2, 2026
- Minimum investment
- $5,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Oct 16, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - StradBio 2026, LLC
What is the minimum investment for AVSF - StradBio 2026, LLC?
According to its latest Form D, filed Oct 16, 2026, the minimum investment AVSF - StradBio 2026, LLC accepts from an outside investor is $5,000.
Who can invest in AVSF - StradBio 2026, LLC?
AVSF - StradBio 2026, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - StradBio 2026, LLC raised?
AVSF - StradBio 2026, LLC reports $386,750 sold from 34 investors on its Form D filed Oct 16, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - StradBio 2026, LLC based?
AVSF - StradBio 2026, LLC is based in Boston, Massachusetts.
When did AVSF - StradBio 2026, LLC launch?
AVSF - StradBio 2026, LLC reports its first sale in Oct 2026, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 48% of the 540 venture capital funds based in Massachusetts, and more than 44% of all 15,160 that report sales.